Luke A Moradi Curtis A Clark Craig S Schneider Alok S Deshane Michael C Dobelbower
10.3389/fimmu.2021.788499
Front Immunol
2021 Dec 8;12:788499.
abscopal effect autoimmune myasthenia gravis immunotherapy case report metastatic melanoma radiation therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/34956219/
Antibodies, Monoclonal, Humanized / therapeutic use Chemoradiotherapy / adverse effects Colitis / drug therapy Immune Checkpoint Inhibitors / therapeutic use Immunosuppressive Agents / therapeutic use Melanoma / therapy Myasthenia Gravis / drug therapy Prednisone / therapeutic use Skin Neoplasms / therapy
Antibodies, Monoclonal, Humanized / therapeutic use Chemoradiotherapy / adverse effects Colitis / drug therapy Immune Checkpoint Inhibitors / therapeutic use Immunosuppressive Agents / therapeutic use Melanoma / therapy Myasthenia Gravis / drug therapy Prednisone / therapeutic use Skin Neoplasms / therapy Case Reports Review Aged Antibodies, Monoclonal, Humanized / adverse effects Colitis / chemically induced Colitis / diagnosis Colitis / immunology Humans Immune Checkpoint Inhibitors / adverse effects Immunocompromised Host Male Melanoma / immunology Melanoma / secondary Myasthenia Gravis / diagnosis Myasthenia Gravis / immunology Skin Neoplasms / immunology Skin Neoplasms / pathology Treatment Outcome Antibodies, Monoclonal, Humanized Immune Checkpoint Inhibitors Immunosuppressive Agents vedolizumab pembrolizumab Prednisone
PMC8692289
34956219
Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis
2021